BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 22182584)

  • 1. Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis.
    Park DM; Song YK; Jee JP; Kim HT; Kim CK
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1077-83. PubMed ID: 22182584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
    Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
    Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of ondansetron liquid suppository for the treatment of emesis.
    Ban E; Kim CK
    Arch Pharm Res; 2013 May; 36(5):586-92. PubMed ID: 23430761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
    Sheshala R; Khan N; Chitneni M; Darwis Y
    Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of mucoadhesive buccal films for the treatment of oral sub-mucous fibrosis: a preliminary study.
    Averineni RK; Sunderajan SG; Mutalik S; Nayak U; Shavi G; Armugam K; Meka SR; Pandey S; Nayanabhirama U
    Pharm Dev Technol; 2009; 14(2):199-207. PubMed ID: 19519192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting.
    Al Abood RM; Talegaonkar S; Tariq M; Ahmad FJ
    Colloids Surf B Biointerfaces; 2013 Jan; 101():143-51. PubMed ID: 22796784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential.
    Beg S; Jena SS; Patra ChN; Rizwan M; Swain S; Sruti J; Rao ME; Singh B
    Colloids Surf B Biointerfaces; 2013 Jan; 101():414-23. PubMed ID: 23010049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of a mucoadhesive buccal film bearing progesterone.
    Jain SK; Jain A; Gupta Y; Kharya A
    Pharmazie; 2008 Feb; 63(2):129-35. PubMed ID: 18380399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetic studies of fast dissolving film and oral solution of ondansetron in rats.
    Choudhary DR; Patel VA; Chhalotiya UK; Patel HV; Kundawala AJ
    Curr Drug Deliv; 2013 Dec; 10(6):696-700. PubMed ID: 23755722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buccal films of prednisolone with enhanced bioavailability.
    Kumria R; Nair AB; Goomber G; Gupta S
    Drug Deliv; 2016; 23(2):471-8. PubMed ID: 24892626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of ondansetron nasal delivery systems.
    Cho E; Gwak H; Chun I
    Int J Pharm; 2008 Feb; 349(1-2):101-7. PubMed ID: 17822864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
    Rana P; Murthy RS
    Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provesicular granisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance.
    Ahmed S; El-Setouhy DA; El-Latif Badawi AA; El-Nabarawi MA
    Eur J Pharm Sci; 2014 Aug; 60():10-23. PubMed ID: 24793896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.
    Mazzarino L; Borsali R; Lemos-Senna E
    J Pharm Sci; 2014 Nov; 103(11):3764-3771. PubMed ID: 25187001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron buccal administration for paediatric use: A comparison between films and wafers.
    Giordani B; Abruzzo A; Prata C; Nicoletta FP; Dalena F; Cerchiara T; Luppi B; Bigucci F
    Int J Pharm; 2020 Apr; 580():119228. PubMed ID: 32184180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive buccal films containing phospholipid-bile salts-mixed micelles as an effective carrier for Cucurbitacin B delivery.
    Lv Q; Shen C; Li X; Shen B; Yu C; Xu P; Xu H; Han J; Yuan H
    Drug Deliv; 2015 May; 22(3):351-8. PubMed ID: 24467528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Tizanidine HCl-Meloxicam loaded mucoadhesive buccal films: In-vitro and in-vivo evaluation.
    Zaman M; Hanif M; Shaheryar ZA
    PLoS One; 2018; 13(3):e0194410. PubMed ID: 29566073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations.
    Yedurkar P; Dhiman MK; Petkar K; Sawant K
    J Microencapsul; 2012; 29(2):126-37. PubMed ID: 22047549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
    Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A
    Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.
    Hassan N; Khar RK; Ali M; Ali J
    AAPS PharmSciTech; 2009; 10(4):1085-92. PubMed ID: 19757080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.